Found: 17
Select item for more details and to access through your institution.
The myelodysplastic syndromes: current approaches to therapy.
- Published in:
- 1990
- By:
- Publication type:
- journal article
The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas.
- Published in:
- 1988
- By:
- Publication type:
- journal article
2'-Deoxycoformycin therapy in adult T-cell leukemia/lymphoma.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Value of open-lung biopsy in 87 immunocompromised patients with pulmonary infiltrates.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Urinary cytodiagnostic abnormalities in 50 patients with non-Hodgkin's lymphomas.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Favorable outcome of central nervous system toxoplasmosis occurring in a patient with untreated Hodgkin's disease.
- Published in:
- 1980
- By:
- Publication type:
- journal article
Meeting highlights from: 49th Annual Meeting of the American Society of Hematology: Atlanta, GA; December 8-11, 2007.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
International harmonization of trial parameters in malignant lymphoma.
- Published in:
- European Journal of Haematology, 2005, v. 75, p. 53, doi. 10.1111/j.1600-0609.2005.00455.x
- By:
- Publication type:
- Article
Homoharringtonine: history, current research, and future direction.
- Published in:
- 2001
- By:
- Publication type:
- journal article
How we manage follicular lymphoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
How we manage follicular lymphoma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 7, p. 1388, doi. 10.1038/leu.2014.91
- By:
- Publication type:
- Article
A PHASE 1 STUDY EVALUATING PRT2527, A POTENT AND HIGHLY SELECTIVE CDK9 INHIBITOR, IN PATIENTS WITH SELECT RELAPSED/REFRACTORY B‐CELL MALIGNANCIES.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 829, doi. 10.1002/hon.3166_OT11
- By:
- Publication type:
- Article
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 381, doi. 10.1002/hon.3164_276
- By:
- Publication type:
- Article
CALGB 50801 (ALLIANCE): PET ADAPTED THERAPY IN BULKY STAGE I/II CLASSIC HODGKIN LYMPHOMA (CHL)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.72_2879
- By:
- Publication type:
- Article
ACALABRUTINIB PLUS PEMBROLIZUMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: A PHASE 1/2 STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 327, doi. 10.1002/hon.139_2630
- By:
- Publication type:
- Article
ACALABRUTINIB PLUS PEMBROLIZUMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: A PHASE 1/2 STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 327, doi. 10.1002/hon.139_2630
- By:
- Publication type:
- Article
Histone deacetylase inhibition: a novel approach to cancer treatment.
- Published in:
- British Journal of Cancer, 2006, v. 95, p. S1, doi. 10.1038/sj.bjc.6603462
- By:
- Publication type:
- Article